AtriCure, Inc. (ATRC) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Atricure, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a0424a-d8ca-7690-b057-ef81a7a0e5dc Created: 2026-08-27T08:16:38.637Z Duration: 2777.3127 Channels: 1 00:00:00.000 -- 00:00:02.720 Good afternoon, and welcome to AtriCure's Second Quarter 00:00:02.720 -- 00:00:05.120 twenty twenty six Earnings Conference Call. 00:00:05.600 -- 00:00:08.320 This call is being recorded for replay purposes. 00:00:08.400 -- 00:00:10.320 And at this time, all participants are in 00:00:10.320 -- 00:00:11.519 a listen only mode. 00:00:12.000 -- 00:00:14.480 We will be facilitating a question and answer 00:00:14.480 -- 00:00:18.304 session following prepared remarks from AtriCure's management. 00:00:18.865 -- 00:00:20.305 I would now like to turn the call 00:00:20.305 -- 00:00:23.185 over to Melissa Beit from the Gilman Group 00:00:23.185 -- 00:00:25.824 for a few introductory comments. You may begin. 00:00:28.710 -- 00:00:29.590 Thank 00:00:29.590 -- 00:00:30.070 you. 00:00:30.550 -- 00:00:32.310 By now, you should have received a copy 00:00:32.310 -- 00:00:33.830 of the earnings press release. 00:00:34.070 -- 00:00:35.910 If you have not received a copy, please 00:00:35.910 -- 00:00:37.350 call (513) 00:00:37.430 -- 00:00:40.150 644-4484 00:00:40.150 -- 00:00:41.430 to have one emailed to you. 00:00:42.445 -- 00:00:44.925 Before we begin today, let me remind you 00:00:44.925 -- 00:00:47.964 that the company's remarks include forward looking statements. 00:00:48.605 -- 00:00:51.405 Forward looking statements are subject to numerous risks 00:00:51.405 -- 00:00:52.524 and uncertainties, 00:00:52.844 -- 00:00:55.960 many of which are beyond AtriCure's control, including 00:00:55.960 -- 00:00:58.920 risks and uncertainties described from time to time 00:00:58.920 -- 00:01:01.239 in Atri...